9,10-phenanthrenequinone has been researched along with 9,10-anthraquinone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lefin, R; Petzer, A; Petzer, JP | 1 |
| Bols, NC; Carlson, JC; DeWitte-Orr, SJ; Greenberg, BM; Nykamp, JA; Passaperuma, K; Peters, ZJ | 1 |
2 other study(ies) available for 9,10-phenanthrenequinone and 9,10-anthraquinone
| Article | Year |
|---|---|
Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase.
Topics: Anthraquinones; Dose-Response Relationship, Drug; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenothiazines; Structure-Activity Relationship | 2022 |
Effect of copper on the cytotoxicity of phenanthrene and 9,10-phenanthrenequinone to the human placental cell line, JEG-3.
Topics: Anthracenes; Anthraquinones; Cell Line, Tumor; Cell Survival; Chelating Agents; Copper; Dose-Response Relationship, Drug; Drug Synergism; Energy Metabolism; Environmental Pollutants; Humans; Oxidation-Reduction; Oxidative Stress; Phenanthrenes; Phenanthrolines; Placenta; Reactive Oxygen Species; Trophoblasts | 2007 |